Kintegral Advisory LLC reduced its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 32.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 29,156 shares of the financial services provider's stock after selling 14,300 shares during the quarter. Kintegral Advisory LLC's holdings in Aflac were worth $3,242,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also made changes to their positions in AFL. Vanguard Group Inc. lifted its stake in Aflac by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider's stock worth $5,310,640,000 after purchasing an additional 653,275 shares during the last quarter. Geode Capital Management LLC raised its holdings in Aflac by 2.4% during the fourth quarter. Geode Capital Management LLC now owns 12,465,433 shares of the financial services provider's stock worth $1,286,042,000 after purchasing an additional 288,482 shares in the last quarter. Northern Trust Corp lifted its position in shares of Aflac by 22.9% during the 4th quarter. Northern Trust Corp now owns 7,296,014 shares of the financial services provider's stock worth $754,700,000 after buying an additional 1,357,753 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Aflac by 11.9% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,250,905 shares of the financial services provider's stock worth $543,154,000 after buying an additional 556,394 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of Aflac in the 4th quarter valued at $349,699,000. 67.44% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at Aflac
In other Aflac news, Director Arthur Reginald Collins sold 2,750 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $105.70, for a total transaction of $290,675.00. Following the transaction, the director owned 6,728 shares in the company, valued at approximately $711,149.60. The trade was a 29.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Masatoshi Koide sold 37,000 shares of the stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total value of $3,906,830.00. Following the transaction, the director directly owned 70,992 shares of the company's stock, valued at approximately $7,496,045.28. This trade represents a 34.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 40,750 shares of company stock worth $4,304,295 over the last ninety days. 0.90% of the stock is currently owned by company insiders.
Analyst Ratings Changes
AFL has been the topic of several research analyst reports. Barclays lifted their price target on shares of Aflac from $95.00 to $96.00 and gave the stock an "underweight" rating in a research note on Thursday, May 1st. Wells Fargo & Company raised their price objective on Aflac from $102.00 to $103.00 and gave the stock an "equal weight" rating in a report on Tuesday, May 6th. Keefe, Bruyette & Woods lifted their target price on Aflac from $104.00 to $106.00 and gave the stock a "market perform" rating in a research report on Wednesday, May 7th. Raymond James Financial decreased their target price on Aflac from $115.00 to $110.00 and set an "outperform" rating for the company in a research report on Thursday, May 29th. Finally, Morgan Stanley raised their price target on Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a research note on Monday, May 19th. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $106.50.
Get Our Latest Research Report on AFL
Aflac Trading Up 1.0%
Shares of AFL stock opened at $104.57 on Friday. The company has a market capitalization of $56.54 billion, a P/E ratio of 16.34, a price-to-earnings-growth ratio of 3.20 and a beta of 0.81. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.29. The business's 50 day moving average is $104.32 and its two-hundred day moving average is $105.21. Aflac Incorporated has a twelve month low of $88.00 and a twelve month high of $115.50.
Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing the consensus estimate of $1.67 by ($0.01). The company had revenue of $3.40 billion for the quarter, compared to analyst estimates of $4.53 billion. Aflac had a return on equity of 15.55% and a net margin of 21.27%. Aflac's revenue for the quarter was down 37.5% compared to the same quarter last year. During the same period in the prior year, the business earned $1.66 earnings per share. Equities analysts forecast that Aflac Incorporated will post 6.88 EPS for the current year.
Aflac Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st were issued a $0.58 dividend. This represents a $2.32 annualized dividend and a dividend yield of 2.22%. The ex-dividend date was Wednesday, May 21st. Aflac's payout ratio is 36.25%.
Aflac Company Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Further Reading
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
